Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Study of the CycloPen Micro-Interventional System and Long-Term Clinical Outcomes

NCT: NCT05506423 · ACTIVE_NOT_RECRUITING

NCT IDNCT05506423
StatusACTIVE_NOT_RECRUITING
Start Date2022-08-17
SponsorIantrek, Inc. (INDUSTRY)
First posted
Last updated

Brief Summary

This observational study will enroll adults with open angle glaucoma (OAG) who had surgery to reduce intraocular pressure (IOP) using the CycloPen Micro-Interventional System. Consenting participants will be followed for 24 months after their surgery. Data regarding IOP, use of glaucoma medications, and any side effects related to the surgery will be collected from participants' preoperative examination, their surgery, and postoperative examinations.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑